Scandent Imaging Ltd (BSE: 516110) is a Thane, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹11 Cr, it ranks #4,758 by market cap among the 6,197 Indian listed companies on FinBizNet, and #14 of 18 in Medical Diagnostic Centres. At ₹1.97 (as of 16 Nov 2026), the share price is 51.7% below its 52-week high of ₹4.08 and 22.4% above its 52-week low of ₹1.61. The share price is down 51.2% over one year and down 15.1% over three months.
| Current Price | ₹1.97 |
|---|---|
| Market Cap | ₹11 Cr |
| BSE Code | 516110 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | Not meaningful (loss) |
| Return on Equity | -75.79% |
| Return on Assets | -11.69% |
| 52-Week Range | ₹1.61 – ₹4.08 |
| 1-Year Price Change | -51.2% |
| 3-Month Price Change | -15.1% |
| Beta (1Y) | 0.39 |
| Dividend Yield | 0.00% |
| Headquarters | Thane, Maharashtra |
| Website | www.familycarehospitals.com |
Delivery averaged 72.4% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Family Care Hospitals Limited engages in the healthcare services business in India. The company offers general surgeries, gynaecology, orthopedics, ENT, cardiology, urology, oncology, plastic surgery, and proctology services. It is also involved in the operation of an online pharmacy application. The company was formerly known as Scandent Imaging Limited and changed its name to Family Care Hospitals Limited in September 2022. Family Care Hospitals Limited was incorporated in 1994 and is based in Thane, India.
1. Healthcare Services-This segment provides healthcare services.
1. Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Dr. Lal Pathlabs Ltd | ₹33,934 Cr | 66.4 | 21.48% | ₹874 Cr | +28.7% |
| Vijaya Diagnostic Centre Limited | ₹14,665 Cr | 84.3 | 19.70% | ₹255 Cr | +38.5% |
| Metropolis Healthcare Limited | ₹11,952 Cr | 61.5 | 13.37% | ₹497 Cr | +14.9% |
| Throcare Technologies Ltd | ₹7,764 Cr | 47.6 | 28.74% | ₹271 Cr | +7.5% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,856 Cr | 55.4 | 13.84% | ₹99 Cr | +6.9% |
| Krsnaa Diagnostics Ltd | ₹1,625 Cr | 16.8 | 10.89% | ₹271 Cr | -27.0% |
| Gaudium IVF and Women Health Limited | ₹803 Cr | 27.4 | 16.08% | ₹37 Cr | — |
| Chandan Healthcare Limited | ₹582 Cr | 21.9 | 18.43% | ₹81 Cr | — |
| Scandent Imaging Ltd | ₹11 Cr | n/m | -75.79% | — | -51.2% |
Listed by market capitalisation. Ratios are shown for context only.
Scandent Imaging Ltd is trading at ₹1.97, with a market capitalisation of ₹11 Cr.
Scandent Imaging Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Scandent Imaging Ltd has a return on equity of -75.79%.
Scandent Imaging Ltd is listed on the BSE under the scrip code 516110.
Scandent Imaging Ltd's share price is down 51.2% over one year and down 15.1% over three months. Its 52-week range is ₹1.61 to ₹4.08.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.